Skip to content

Analysis of Psychoneuroimmunological Parameters of Health in Specific Population Groups in Slovakia

Analysis of Psychoneuroimmunological Parameters of Health in Specific Population Groups in Slovakia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07070180
Acronym
APNIP
Enrollment
700
Registered
2025-07-17
Start date
2024-01-01
Completion date
2025-12-15
Last updated
2026-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Childhood Experience, Anxiety Symptoms, Cytokine Levels, Depression Symptoms, Immunity, Mindfulness, Positive Thinking, Problem Solving, Psychological Adaptation, Psychological Distress, Resilience, Self-control, Sense of Coherence, Sense of Control, Socio-economic Status, Stress, Stress Response

Keywords

psychological immunity, biological immunity, psychoneuroimmunology

Brief summary

This study aims to investigate the links between psychological and biological immunity from the perspective of psychology, epidemiology, and immunology in a general population study sample as well as in a specific group of people in treatment for alcohol addiction.

Detailed description

The study will explore the associations between the level of psychological immunity and the current psychological state of the participants, possible links between the level of psychological immunity in adulthood and adverse childhood experiences, and finally, the association between the psychological immunity and biological immunity expressed by the self- assessed perceived immune status and on a molecular level by quantity of cytokines and in a specific subgroup also by natural killer cells. All this will be studied in a sample of general population as well as in a specific group of people in treatment for alcohol addiction that was chosen based on the known adverse immune-related health effects of excessive alcohol consumption.

Interventions

None listed

Sponsors

Comenius University
Lead SponsorOTHER
Slovak Academy of Sciences
CollaboratorOTHER_GOV

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

for 'General Slovak Population Sample': * Age between 18 - 50 years * Residency in the respective region for at least five years * Consent to participate in the study

Exclusion criteria

for 'General Slovak Population Sample': * Individuals younger than 18 or older than 50 years * Ongoing acute infectious disease on the day of testing * Eligible individuals who do not provide informed consent Inclusion Criteria for the sample 'Individuals receiving inpatient treatment for alcohol addiction at the treatment facility': * Age between 18 - 50 years * Admission to treatment for alcohol addiction * Consent to participate in the study, Treatment completion

Design outcomes

Primary

MeasureTime frameDescription
The primary outcome measure is the correlation between psychological immunity, current health status and cytokine levels as indicators of biological immune function.At the time of study enrollment for Group 1, at the time of admission in treatment and after completion of 3 months of treatment for Group 2The psychological instrument will consist of the Psychological immune competence inventory (PICI) to assess the psychological immunity. Current health status will be assessed by the epidemiological instrument that will evaluate self-assessed immune status, overall, mental, and physical health, current long-term conditions, social, and economic status. Units of measure for the questionnaires is a score. Cytokine secretion by immune cells will be tested using Bio-Plex ProTM Human Cytokine 17- plex assay according to the instructions of the manufacturer. For the analysis the blood plasma will be used. In each sample the following panel of cytokines will be analysed: G- CSF, GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p70), IL-13, IL-17A, MCP-1 (MCAF), MIP-1β, TNF-α. Cytokine units of measure are picograms per milliliter.

Countries

Slovakia

Contacts

PRINCIPAL_INVESTIGATORAlexandra Bražinová, prof., MD, PhD

Comenius University, Faculty of Medicine in Bratislava

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026